- Report
- January 2022
- 60 Pages
Global
From €3819EUR$3,950USD£3,282GBP
- Report
- January 2022
- 60 Pages
Global
From €3819EUR$3,950USD£3,282GBP
- Report
- August 2020
- 100 Pages
Global
From €3625EUR$3,750USD£3,116GBP
- Report
- February 2020
- 253 Pages
Global
From €6042EUR$6,250USD£5,193GBP
- Report
- May 2021
- 112 Pages
Global
From €4350EUR$4,500USD£3,739GBP
- Report
- September 2021
- 40 Pages
China
From €2513EUR$2,600USD£2,160GBP
- Report
- September 2021
- 40 Pages
China
From €2513EUR$2,600USD£2,160GBP
- Report
- October 2018
- 104 Pages
Global
From €2658EUR$2,750USD£2,285GBP
- Report
- March 2019
- 17 Pages
Global
€9667EUR$10,000USD£8,309GBP
- Report
- March 2019
- 17 Pages
Global
€9667EUR$10,000USD£8,309GBP
- Report
- March 2019
- 20 Pages
Global
€9667EUR$10,000USD£8,309GBP
- Report
- March 2019
- 20 Pages
Global
€9667EUR$10,000USD£8,309GBP
- Report
- March 2019
- 16 Pages
Global
€9667EUR$10,000USD£8,309GBP
- Report
- March 2019
- 17 Pages
Global
€9667EUR$10,000USD£8,309GBP
- Report
- March 2019
- 17 Pages
Global
€9667EUR$10,000USD£8,309GBP
- Report
- July 2022
- 120 Pages
Global
From €2417EUR$2,500USD£2,077GBP
- Report
- March 2021
- 120 Pages
Global
From €2417EUR$2,500USD£2,077GBP
- Report
- January 2020
- 100 Pages
Global
From €2417EUR$2,500USD£2,077GBP
- Report
- August 2022
United States
From €1875EUR$1,940USD£1,612GBP
- Report
- August 2022
Global
From €1054EUR$1,090USD£906GBP
The Antidepressant market is a subset of the Mental Disorders Drugs market, which includes medications used to treat mental health conditions such as depression, anxiety, bipolar disorder, and schizophrenia. Antidepressants are the most commonly prescribed medications for treating depression, and are typically divided into two categories: selective serotonin reuptake inhibitors (SSRIs) and serotonin-norepinephrine reuptake inhibitors (SNRIs). These medications work by increasing the levels of serotonin and norepinephrine in the brain, which can help to improve mood and reduce symptoms of depression.
Some of the major companies in the Antidepressant market include Eli Lilly, Pfizer, GlaxoSmithKline, AstraZeneca, and Bristol-Myers Squibb. These companies produce a variety of antidepressants, including SSRIs and SNRIs, as well as other medications used to treat mental health conditions. Show Less Read more